View Future GrowthDAIHAN Scientific 過去の業績過去 基準チェック /56DAIHAN Scientificは、平均年間0.3%の収益成長を遂げていますが、 Electronic業界の収益は、年間 成長しています。収益は、平均年間7.5% 4.3%収益成長率で 成長しています。 DAIHAN Scientificの自己資本利益率は8.4%であり、純利益率は4%です。主要情報0.27%収益成長率1.27%EPS成長率Electronic 業界の成長21.63%収益成長率4.27%株主資本利益率8.42%ネット・マージン4.05%前回の決算情報31 Dec 2025最近の業績更新Reported Earnings • Mar 24Full year 2025 earnings released: EPS: ₩478 (vs ₩386 in FY 2024)Full year 2025 results: EPS: ₩478 (up from ₩386 in FY 2024). Revenue: ₩81.1b (up 13% from FY 2024). Net income: ₩3.28b (up 22% from FY 2024). Profit margin: 4.0% (up from 3.8% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 12% per year whereas the company’s share price has fallen by 13% per year.分析記事 • Aug 27Shareholders Can Be Confident That DAIHAN Scientific's (KOSDAQ:131220) Earnings Are High QualityEven though DAIHAN Scientific Co., Ltd.'s ( KOSDAQ:131220 ) recent earnings release was robust, the market didn't seem...Reported Earnings • Mar 20Full year 2024 earnings released: EPS: ₩386 (vs ₩543 in FY 2023)Full year 2024 results: EPS: ₩386 (down from ₩543 in FY 2023). Revenue: ₩71.7b (down 2.7% from FY 2023). Net income: ₩2.69b (down 30% from FY 2023). Profit margin: 3.8% (down from 5.2% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has fallen by 25% per year, which means it is performing significantly worse than earnings.Reported Earnings • Mar 22Full year 2022 earnings released: EPS: ₩657 (vs ₩524 in FY 2021)Full year 2022 results: EPS: ₩657 (up from ₩524 in FY 2021). Revenue: ₩72.3b (up 9.1% from FY 2021). Net income: ₩4.70b (up 25% from FY 2021). Profit margin: 6.5% (up from 5.7% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth.Reported Earnings • Mar 18Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: ₩524 (up from ₩237 in FY 2020). Revenue: ₩66.3b (up 7.8% from FY 2020). Net income: ₩3.77b (up 120% from FY 2020). Profit margin: 5.7% (up from 2.8% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 30% per year whereas the company’s share price has increased by 26% per year.Reported Earnings • Mar 18Full year 2020 earnings released: EPS ₩229 (vs ₩165 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₩61.5b (up 12% from FY 2019). Net income: ₩1.71b (up 39% from FY 2019). Profit margin: 2.8% (up from 2.2% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth.すべての更新を表示Recent updatesReported Earnings • Mar 24Full year 2025 earnings released: EPS: ₩478 (vs ₩386 in FY 2024)Full year 2025 results: EPS: ₩478 (up from ₩386 in FY 2024). Revenue: ₩81.1b (up 13% from FY 2024). Net income: ₩3.28b (up 22% from FY 2024). Profit margin: 4.0% (up from 3.8% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 12% per year whereas the company’s share price has fallen by 13% per year.お知らせ • Mar 04DAIHAN Scientific Co., Ltd., Annual General Meeting, Mar 27, 2026DAIHAN Scientific Co., Ltd., Annual General Meeting, Mar 27, 2026, at 09:30 Tokyo Standard Time. Location: auditorium, 326, sinpyeongseokhwa-ro, jijeong-myeon, gangwon-do, wonju South KoreaUpcoming Dividend • Dec 22Upcoming dividend of ₩60.00 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 13 April 2026. Payout ratio is a comfortable 10.0% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of South Korean dividend payers (3.6%). Higher than average of industry peers (0.9%).分析記事 • Nov 09DAIHAN Scientific (KOSDAQ:131220) Is Paying Out A Dividend Of ₩60.00The board of DAIHAN Scientific Co., Ltd. ( KOSDAQ:131220 ) has announced that it will pay a dividend on the 13th of...Declared Dividend • Nov 08Dividend of ₩60.00 announcedDividend of ₩60.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 13th April 2026 Dividend yield will be 1.3%, which is higher than the industry average of 0.9%. Sustainability & Growth Dividend is well covered by both earnings (13% earnings payout ratio) and cash flows (6% cash payout ratio). The dividend has not increased over the past 6 years but payments have been stable during that time. Earnings per share has grown by 16% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Nov 07DAIHAN Scientific Co., Ltd. announces Annual dividend, payable on April 13, 2026DAIHAN Scientific Co., Ltd. announced Annual dividend of KRW 60.0000 per share payable on April 13, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.分析記事 • Aug 27Shareholders Can Be Confident That DAIHAN Scientific's (KOSDAQ:131220) Earnings Are High QualityEven though DAIHAN Scientific Co., Ltd.'s ( KOSDAQ:131220 ) recent earnings release was robust, the market didn't seem...New Risk • May 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (₩38.5b market cap, or US$27.1m).分析記事 • Apr 21Optimistic Investors Push DAIHAN Scientific Co., Ltd. (KOSDAQ:131220) Shares Up 29% But Growth Is LackingThe DAIHAN Scientific Co., Ltd. ( KOSDAQ:131220 ) share price has done very well over the last month, posting an...Valuation Update With 7 Day Price Move • Apr 21Investor sentiment improves as stock rises 29%After last week's 29% share price gain to ₩5,680, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 12x in the Electronic industry in South Korea. Total loss to shareholders of 37% over the past three years.Buy Or Sell Opportunity • Apr 07Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 9.4% to ₩4,250. The fair value is estimated to be ₩5,338, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 18%.Reported Earnings • Mar 20Full year 2024 earnings released: EPS: ₩386 (vs ₩543 in FY 2023)Full year 2024 results: EPS: ₩386 (down from ₩543 in FY 2023). Revenue: ₩71.7b (down 2.7% from FY 2023). Net income: ₩2.69b (down 30% from FY 2023). Profit margin: 3.8% (down from 5.2% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has fallen by 25% per year, which means it is performing significantly worse than earnings.お知らせ • Mar 15DAIHAN Scientific Co., Ltd., Annual General Meeting, Mar 28, 2025DAIHAN Scientific Co., Ltd., Annual General Meeting, Mar 28, 2025, at 09:30 Tokyo Standard Time. Location: auditorium, 326, sinpyeongseokhwa-ro, jijeong-myeon, gangwon-do, wonju South KoreaUpcoming Dividend • Dec 20Upcoming dividend of ₩60.00 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 14 April 2025. Payout ratio is a comfortable 21% and this is well supported by cash flows. Trailing yield: 1.3%. Lower than top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (1.0%).New Risk • Dec 16New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Market cap is less than US$100m (₩34.6b market cap, or US$24.1m).New Risk • Sep 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₩36.2b market cap, or US$27.5m).Valuation Update With 7 Day Price Move • Aug 27Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩5,140, the stock trades at a trailing P/E ratio of 15x. Average trailing P/E is 13x in the Electronic industry in South Korea. Total loss to shareholders of 54% over the past three years.Upcoming Dividend • Dec 20Upcoming dividend of ₩60.00 per share at 1.0% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 08 April 2024. Payout ratio is a comfortable 11% and this is well supported by cash flows. Trailing yield: 1.0%. Lower than top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (0.9%).Reported Earnings • Mar 22Full year 2022 earnings released: EPS: ₩657 (vs ₩524 in FY 2021)Full year 2022 results: EPS: ₩657 (up from ₩524 in FY 2021). Revenue: ₩72.3b (up 9.1% from FY 2021). Net income: ₩4.70b (up 25% from FY 2021). Profit margin: 6.5% (up from 5.7% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • Dec 21Upcoming dividend of ₩60.00 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 10 April 2023. Payout ratio is a comfortable 7.8% but the company is not cash flow positive. Trailing yield: 0.8%. Lower than top quartile of South Korean dividend payers (3.2%). Lower than average of industry peers (1.0%).Board Change • Nov 16No independent directorsThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: No independent directors. 11 non-independent directors. Chairman of Vietnam Market - SciLab-Vietnam Henry Pay was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity.Valuation Update With 7 Day Price Move • Jul 20Investor sentiment improved over the past weekAfter last week's 35% share price gain to ₩11,000, the stock trades at a trailing P/E ratio of 17.4x. Average trailing P/E is 13x in the Electronic industry in South Korea. Total returns to shareholders of 117% over the past three years.Valuation Update With 7 Day Price Move • Jun 29Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₩7,200, the stock trades at a trailing P/E ratio of 11.4x. Average trailing P/E is 13x in the Electronic industry in South Korea. Total returns to shareholders of 41% over the past three years.Valuation Update With 7 Day Price Move • Jun 15Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩7,460, the stock trades at a trailing P/E ratio of 11.8x. Average trailing P/E is 13x in the Electronic industry in South Korea. Total returns to shareholders of 42% over the past three years.Board Change • Apr 27No independent directorsThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: No independent directors. 11 non-independent directors. Chairman of Vietnam Market - SciLab-Vietnam Henry Pay was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity.Reported Earnings • Mar 18Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: ₩524 (up from ₩237 in FY 2020). Revenue: ₩66.3b (up 7.8% from FY 2020). Net income: ₩3.77b (up 120% from FY 2020). Profit margin: 5.7% (up from 2.8% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 30% per year whereas the company’s share price has increased by 26% per year.Valuation Update With 7 Day Price Move • Mar 14Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₩9,460, the stock trades at a trailing P/E ratio of 21.8x. Average trailing P/E is 17x in the Electronic industry in South Korea. Total returns to shareholders of 86% over the past three years.Valuation Update With 7 Day Price Move • Jan 27Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩7,610, the stock trades at a trailing P/E ratio of 17.5x. Average trailing P/E is 17x in the Electronic industry in South Korea. Total returns to shareholders of 57% over the past three years.Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₩11,200, the stock trades at a trailing P/E ratio of 25.8x. Average trailing P/E is 19x in the Electronic industry in South Korea. Total returns to shareholders of 158% over the past three years.Upcoming Dividend • Dec 22Upcoming dividend of ₩60.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 11 April 2022. Payout ratio is a comfortable 14% and this is well supported by cash flows. Trailing yield: 0.7%. Lower than top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (0.4%).Valuation Update With 7 Day Price Move • May 03Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to ₩16,050, the stock trades at a trailing P/E ratio of 70x. Average trailing P/E is 25x in the Electronic industry in South Korea. Total returns to shareholders of 157% over the past three years.Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₩13,750, the stock trades at a trailing P/E ratio of 59.9x. Average trailing P/E is 25x in the Electronic industry in South Korea. Total returns to shareholders of 140% over the past three years.分析記事 • Apr 12Does DAIHAN Scientific (KOSDAQ:131220) Deserve A Spot On Your Watchlist?Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...分析記事 • Mar 29A Look At The Fair Value Of DAIHAN Scientific Co., Ltd. (KOSDAQ:131220)Does the March share price for DAIHAN Scientific Co., Ltd. ( KOSDAQ:131220 ) reflect what it's really worth? Today, we...Reported Earnings • Mar 18Full year 2020 earnings released: EPS ₩229 (vs ₩165 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₩61.5b (up 12% from FY 2019). Net income: ₩1.71b (up 39% from FY 2019). Profit margin: 2.8% (up from 2.2% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth.分析記事 • Mar 11The DAIHAN Scientific (KOSDAQ:131220) Share Price Has Gained 173%, So Why Not Pay It Some Attention?The last three months have been tough on DAIHAN Scientific Co., Ltd. ( KOSDAQ:131220 ) shareholders, who have seen the...分析記事 • Feb 18Shareholders Are Loving DAIHAN Scientific Co., Ltd.'s (KOSDAQ:131220) 0.4% YieldCould DAIHAN Scientific Co., Ltd. ( KOSDAQ:131220 ) be an attractive dividend share to own for the long haul? Investors...Is New 90 Day High Low • Feb 18New 90-day low: ₩15,600The company is down 19% from its price of ₩19,150 on 20 November 2020. The South Korean market is up 22% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 41% over the same period.分析記事 • Jan 24We Like These Underlying Trends At DAIHAN Scientific (KOSDAQ:131220)What are the early trends we should look for to identify a stock that could multiply in value over the long term...分析記事 • Dec 27What Type Of Shareholders Own The Most Number of DAIHAN Scientific Co., Ltd. (KOSDAQ:131220) Shares?Every investor in DAIHAN Scientific Co., Ltd. ( KOSDAQ:131220 ) should be aware of the most powerful shareholder...Upcoming Dividend • Dec 22Upcoming Dividend of ₩60.00 Per ShareWill be paid on the 10th of April to those who are registered shareholders by the 29th of December. The trailing yield of 0.3% is below the top quartile of South Korean dividend payers (2.6%), and is lower than industry peers (0.5%).分析記事 • Nov 30DAIHAN Scientific Co., Ltd.'s (KOSDAQ:131220) Stock Is Going Strong: Is the Market Following Fundamentals?DAIHAN Scientific (KOSDAQ:131220) has had a great run on the share market with its stock up by a significant 206% over...Valuation Update With 7 Day Price Move • Nov 13Market bids up stock over the past weekAfter last week's 34% share price gain to ₩15,450, the stock is trading at a trailing P/E ratio of 76.1x, up from the previous P/E ratio of 56.9x. This compares to an average P/E of 23x in the Electronic industry in South Korea. Total returns to shareholders over the past three years are 191%.Is New 90 Day High Low • Nov 10New 90-day high: ₩16,300The company is up 182% from its price of ₩5,780 on 12 August 2020. The South Korean market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 3.0% over the same period.Valuation Update With 7 Day Price Move • Nov 09Market bids up stock over the past weekAfter last week's 15% share price gain to ₩12,550, the stock is trading at a trailing P/E ratio of 61.8x, up from the previous P/E ratio of 53.7x. This compares to an average P/E of 22x in the Electronic industry in South Korea. Total returns to shareholders over the past three years are 137%.Valuation Update With 7 Day Price Move • Oct 29Market pulls back on stock over the past weekAfter last week's 18% share price decline to ₩10,450, the stock is trading at a trailing P/E ratio of 51.5x, down from the previous P/E ratio of 62.6x. This compares to an average P/E of 22x in the Electronic industry in South Korea. Total returns to shareholders over the past three years are 105%.Valuation Update With 7 Day Price Move • Oct 21Market bids up stock over the past weekAfter last week's 36% share price gain to ₩10,750, the stock is trading at a trailing P/E ratio of 53x, up from the previous P/E ratio of 39x. This compares to an average P/E of 22x in the Electronic industry in South Korea. Total returns to shareholders over the past three years are 128%.Is New 90 Day High Low • Oct 21New 90-day high: ₩10,750The company is up 86% from its price of ₩5,780 on 23 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 5.0% over the same period.分析記事 • Jul 14Is DAIHAN Scientific Co., Ltd. (KOSDAQ:131220) A Good Fit For Your Dividend Portfolio?Today we'll take a closer look at DAIHAN Scientific Co., Ltd. (KOSDAQ:131220) from a dividend investor's perspective...収支内訳DAIHAN Scientific の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史KOSDAQ:A131220 収益、費用、利益 ( )KRW Millions日付収益収益G+A経費研究開発費31 Dec 2581,1183,28114,2431,16530 Sep 2577,6434,14113,4021,02130 Jun 2574,8743,17113,3051,02131 Mar 2573,4872,67013,2651,02131 Dec 2471,6942,69313,0991,02130 Sep 2470,6631,99413,78697130 Jun 2470,6352,56213,75397131 Mar 2472,3883,73413,59397131 Dec 2373,7023,84513,57997130 Sep 2375,1044,03813,93282130 Jun 2374,7414,38613,37982131 Mar 2372,3533,90712,92782131 Dec 2272,2804,70212,29882130 Sep 2270,1165,37211,55575930 Jun 2267,8874,92211,00275931 Mar 2267,6354,71710,87975931 Dec 2166,2813,76710,70875930 Sep 2163,5653,24010,01575230 Jun 2162,3652,32910,03475231 Mar 2161,6941,9849,78075231 Dec 2061,5081,7099,89475230 Sep 2060,1311,4329,82580730 Jun 2058,2901,5179,86080731 Mar 2056,0811,20810,04280731 Dec 1955,1651,2279,80180730 Sep 1954,5441,6349,81081730 Jun 1952,2371,6119,47281731 Mar 1949,1871,5178,76481731 Dec 1847,0561,7858,44481730 Sep 1844,6851,4458,17074130 Jun 1843,7441,3578,07574131 Mar 1842,6931,3538,38174131 Dec 1741,3651,0188,38574130 Sep 1741,4241,0058,49397030 Jun 1742,4778298,30897031 Mar 1744,4481,1607,99697031 Dec 1646,0711,8248,20197030 Sep 1646,1222947,8761,30930 Jun 1645,6023138,0471,30931 Mar 1644,057-7938,7901,30931 Dec 1541,605-1,5198,6381,30930 Sep 1541,294308,3471,27230 Jun 1540,034-168,2701,272質の高い収益: A131220は 高品質の収益 を持っています。利益率の向上: A131220の現在の純利益率 (4%)は、昨年(3.8%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: A131220の収益は過去 5 年間で年間0.3%増加しました。成長の加速: A131220の過去 1 年間の収益成長率 ( 21.9% ) は、5 年間の平均 ( 年間0.3%を上回っています。収益対業界: A131220の過去 1 年間の収益成長率 ( 21.9% ) はElectronic業界-2.4%を上回りました。株主資本利益率高いROE: A131220の 自己資本利益率 ( 8.4% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YTech 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/23 01:12終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋DAIHAN Scientific Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • Mar 24Full year 2025 earnings released: EPS: ₩478 (vs ₩386 in FY 2024)Full year 2025 results: EPS: ₩478 (up from ₩386 in FY 2024). Revenue: ₩81.1b (up 13% from FY 2024). Net income: ₩3.28b (up 22% from FY 2024). Profit margin: 4.0% (up from 3.8% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 12% per year whereas the company’s share price has fallen by 13% per year.
分析記事 • Aug 27Shareholders Can Be Confident That DAIHAN Scientific's (KOSDAQ:131220) Earnings Are High QualityEven though DAIHAN Scientific Co., Ltd.'s ( KOSDAQ:131220 ) recent earnings release was robust, the market didn't seem...
Reported Earnings • Mar 20Full year 2024 earnings released: EPS: ₩386 (vs ₩543 in FY 2023)Full year 2024 results: EPS: ₩386 (down from ₩543 in FY 2023). Revenue: ₩71.7b (down 2.7% from FY 2023). Net income: ₩2.69b (down 30% from FY 2023). Profit margin: 3.8% (down from 5.2% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has fallen by 25% per year, which means it is performing significantly worse than earnings.
Reported Earnings • Mar 22Full year 2022 earnings released: EPS: ₩657 (vs ₩524 in FY 2021)Full year 2022 results: EPS: ₩657 (up from ₩524 in FY 2021). Revenue: ₩72.3b (up 9.1% from FY 2021). Net income: ₩4.70b (up 25% from FY 2021). Profit margin: 6.5% (up from 5.7% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Mar 18Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: ₩524 (up from ₩237 in FY 2020). Revenue: ₩66.3b (up 7.8% from FY 2020). Net income: ₩3.77b (up 120% from FY 2020). Profit margin: 5.7% (up from 2.8% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 30% per year whereas the company’s share price has increased by 26% per year.
Reported Earnings • Mar 18Full year 2020 earnings released: EPS ₩229 (vs ₩165 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₩61.5b (up 12% from FY 2019). Net income: ₩1.71b (up 39% from FY 2019). Profit margin: 2.8% (up from 2.2% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Mar 24Full year 2025 earnings released: EPS: ₩478 (vs ₩386 in FY 2024)Full year 2025 results: EPS: ₩478 (up from ₩386 in FY 2024). Revenue: ₩81.1b (up 13% from FY 2024). Net income: ₩3.28b (up 22% from FY 2024). Profit margin: 4.0% (up from 3.8% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 12% per year whereas the company’s share price has fallen by 13% per year.
お知らせ • Mar 04DAIHAN Scientific Co., Ltd., Annual General Meeting, Mar 27, 2026DAIHAN Scientific Co., Ltd., Annual General Meeting, Mar 27, 2026, at 09:30 Tokyo Standard Time. Location: auditorium, 326, sinpyeongseokhwa-ro, jijeong-myeon, gangwon-do, wonju South Korea
Upcoming Dividend • Dec 22Upcoming dividend of ₩60.00 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 13 April 2026. Payout ratio is a comfortable 10.0% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of South Korean dividend payers (3.6%). Higher than average of industry peers (0.9%).
分析記事 • Nov 09DAIHAN Scientific (KOSDAQ:131220) Is Paying Out A Dividend Of ₩60.00The board of DAIHAN Scientific Co., Ltd. ( KOSDAQ:131220 ) has announced that it will pay a dividend on the 13th of...
Declared Dividend • Nov 08Dividend of ₩60.00 announcedDividend of ₩60.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 13th April 2026 Dividend yield will be 1.3%, which is higher than the industry average of 0.9%. Sustainability & Growth Dividend is well covered by both earnings (13% earnings payout ratio) and cash flows (6% cash payout ratio). The dividend has not increased over the past 6 years but payments have been stable during that time. Earnings per share has grown by 16% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Nov 07DAIHAN Scientific Co., Ltd. announces Annual dividend, payable on April 13, 2026DAIHAN Scientific Co., Ltd. announced Annual dividend of KRW 60.0000 per share payable on April 13, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.
分析記事 • Aug 27Shareholders Can Be Confident That DAIHAN Scientific's (KOSDAQ:131220) Earnings Are High QualityEven though DAIHAN Scientific Co., Ltd.'s ( KOSDAQ:131220 ) recent earnings release was robust, the market didn't seem...
New Risk • May 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (₩38.5b market cap, or US$27.1m).
分析記事 • Apr 21Optimistic Investors Push DAIHAN Scientific Co., Ltd. (KOSDAQ:131220) Shares Up 29% But Growth Is LackingThe DAIHAN Scientific Co., Ltd. ( KOSDAQ:131220 ) share price has done very well over the last month, posting an...
Valuation Update With 7 Day Price Move • Apr 21Investor sentiment improves as stock rises 29%After last week's 29% share price gain to ₩5,680, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 12x in the Electronic industry in South Korea. Total loss to shareholders of 37% over the past three years.
Buy Or Sell Opportunity • Apr 07Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 9.4% to ₩4,250. The fair value is estimated to be ₩5,338, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 18%.
Reported Earnings • Mar 20Full year 2024 earnings released: EPS: ₩386 (vs ₩543 in FY 2023)Full year 2024 results: EPS: ₩386 (down from ₩543 in FY 2023). Revenue: ₩71.7b (down 2.7% from FY 2023). Net income: ₩2.69b (down 30% from FY 2023). Profit margin: 3.8% (down from 5.2% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has fallen by 25% per year, which means it is performing significantly worse than earnings.
お知らせ • Mar 15DAIHAN Scientific Co., Ltd., Annual General Meeting, Mar 28, 2025DAIHAN Scientific Co., Ltd., Annual General Meeting, Mar 28, 2025, at 09:30 Tokyo Standard Time. Location: auditorium, 326, sinpyeongseokhwa-ro, jijeong-myeon, gangwon-do, wonju South Korea
Upcoming Dividend • Dec 20Upcoming dividend of ₩60.00 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 14 April 2025. Payout ratio is a comfortable 21% and this is well supported by cash flows. Trailing yield: 1.3%. Lower than top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (1.0%).
New Risk • Dec 16New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Market cap is less than US$100m (₩34.6b market cap, or US$24.1m).
New Risk • Sep 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₩36.2b market cap, or US$27.5m).
Valuation Update With 7 Day Price Move • Aug 27Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩5,140, the stock trades at a trailing P/E ratio of 15x. Average trailing P/E is 13x in the Electronic industry in South Korea. Total loss to shareholders of 54% over the past three years.
Upcoming Dividend • Dec 20Upcoming dividend of ₩60.00 per share at 1.0% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 08 April 2024. Payout ratio is a comfortable 11% and this is well supported by cash flows. Trailing yield: 1.0%. Lower than top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (0.9%).
Reported Earnings • Mar 22Full year 2022 earnings released: EPS: ₩657 (vs ₩524 in FY 2021)Full year 2022 results: EPS: ₩657 (up from ₩524 in FY 2021). Revenue: ₩72.3b (up 9.1% from FY 2021). Net income: ₩4.70b (up 25% from FY 2021). Profit margin: 6.5% (up from 5.7% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • Dec 21Upcoming dividend of ₩60.00 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 10 April 2023. Payout ratio is a comfortable 7.8% but the company is not cash flow positive. Trailing yield: 0.8%. Lower than top quartile of South Korean dividend payers (3.2%). Lower than average of industry peers (1.0%).
Board Change • Nov 16No independent directorsThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: No independent directors. 11 non-independent directors. Chairman of Vietnam Market - SciLab-Vietnam Henry Pay was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity.
Valuation Update With 7 Day Price Move • Jul 20Investor sentiment improved over the past weekAfter last week's 35% share price gain to ₩11,000, the stock trades at a trailing P/E ratio of 17.4x. Average trailing P/E is 13x in the Electronic industry in South Korea. Total returns to shareholders of 117% over the past three years.
Valuation Update With 7 Day Price Move • Jun 29Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₩7,200, the stock trades at a trailing P/E ratio of 11.4x. Average trailing P/E is 13x in the Electronic industry in South Korea. Total returns to shareholders of 41% over the past three years.
Valuation Update With 7 Day Price Move • Jun 15Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩7,460, the stock trades at a trailing P/E ratio of 11.8x. Average trailing P/E is 13x in the Electronic industry in South Korea. Total returns to shareholders of 42% over the past three years.
Board Change • Apr 27No independent directorsThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: No independent directors. 11 non-independent directors. Chairman of Vietnam Market - SciLab-Vietnam Henry Pay was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity.
Reported Earnings • Mar 18Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: ₩524 (up from ₩237 in FY 2020). Revenue: ₩66.3b (up 7.8% from FY 2020). Net income: ₩3.77b (up 120% from FY 2020). Profit margin: 5.7% (up from 2.8% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 30% per year whereas the company’s share price has increased by 26% per year.
Valuation Update With 7 Day Price Move • Mar 14Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₩9,460, the stock trades at a trailing P/E ratio of 21.8x. Average trailing P/E is 17x in the Electronic industry in South Korea. Total returns to shareholders of 86% over the past three years.
Valuation Update With 7 Day Price Move • Jan 27Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩7,610, the stock trades at a trailing P/E ratio of 17.5x. Average trailing P/E is 17x in the Electronic industry in South Korea. Total returns to shareholders of 57% over the past three years.
Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₩11,200, the stock trades at a trailing P/E ratio of 25.8x. Average trailing P/E is 19x in the Electronic industry in South Korea. Total returns to shareholders of 158% over the past three years.
Upcoming Dividend • Dec 22Upcoming dividend of ₩60.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 11 April 2022. Payout ratio is a comfortable 14% and this is well supported by cash flows. Trailing yield: 0.7%. Lower than top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (0.4%).
Valuation Update With 7 Day Price Move • May 03Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to ₩16,050, the stock trades at a trailing P/E ratio of 70x. Average trailing P/E is 25x in the Electronic industry in South Korea. Total returns to shareholders of 157% over the past three years.
Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₩13,750, the stock trades at a trailing P/E ratio of 59.9x. Average trailing P/E is 25x in the Electronic industry in South Korea. Total returns to shareholders of 140% over the past three years.
分析記事 • Apr 12Does DAIHAN Scientific (KOSDAQ:131220) Deserve A Spot On Your Watchlist?Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
分析記事 • Mar 29A Look At The Fair Value Of DAIHAN Scientific Co., Ltd. (KOSDAQ:131220)Does the March share price for DAIHAN Scientific Co., Ltd. ( KOSDAQ:131220 ) reflect what it's really worth? Today, we...
Reported Earnings • Mar 18Full year 2020 earnings released: EPS ₩229 (vs ₩165 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₩61.5b (up 12% from FY 2019). Net income: ₩1.71b (up 39% from FY 2019). Profit margin: 2.8% (up from 2.2% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth.
分析記事 • Mar 11The DAIHAN Scientific (KOSDAQ:131220) Share Price Has Gained 173%, So Why Not Pay It Some Attention?The last three months have been tough on DAIHAN Scientific Co., Ltd. ( KOSDAQ:131220 ) shareholders, who have seen the...
分析記事 • Feb 18Shareholders Are Loving DAIHAN Scientific Co., Ltd.'s (KOSDAQ:131220) 0.4% YieldCould DAIHAN Scientific Co., Ltd. ( KOSDAQ:131220 ) be an attractive dividend share to own for the long haul? Investors...
Is New 90 Day High Low • Feb 18New 90-day low: ₩15,600The company is down 19% from its price of ₩19,150 on 20 November 2020. The South Korean market is up 22% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 41% over the same period.
分析記事 • Jan 24We Like These Underlying Trends At DAIHAN Scientific (KOSDAQ:131220)What are the early trends we should look for to identify a stock that could multiply in value over the long term...
分析記事 • Dec 27What Type Of Shareholders Own The Most Number of DAIHAN Scientific Co., Ltd. (KOSDAQ:131220) Shares?Every investor in DAIHAN Scientific Co., Ltd. ( KOSDAQ:131220 ) should be aware of the most powerful shareholder...
Upcoming Dividend • Dec 22Upcoming Dividend of ₩60.00 Per ShareWill be paid on the 10th of April to those who are registered shareholders by the 29th of December. The trailing yield of 0.3% is below the top quartile of South Korean dividend payers (2.6%), and is lower than industry peers (0.5%).
分析記事 • Nov 30DAIHAN Scientific Co., Ltd.'s (KOSDAQ:131220) Stock Is Going Strong: Is the Market Following Fundamentals?DAIHAN Scientific (KOSDAQ:131220) has had a great run on the share market with its stock up by a significant 206% over...
Valuation Update With 7 Day Price Move • Nov 13Market bids up stock over the past weekAfter last week's 34% share price gain to ₩15,450, the stock is trading at a trailing P/E ratio of 76.1x, up from the previous P/E ratio of 56.9x. This compares to an average P/E of 23x in the Electronic industry in South Korea. Total returns to shareholders over the past three years are 191%.
Is New 90 Day High Low • Nov 10New 90-day high: ₩16,300The company is up 182% from its price of ₩5,780 on 12 August 2020. The South Korean market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 3.0% over the same period.
Valuation Update With 7 Day Price Move • Nov 09Market bids up stock over the past weekAfter last week's 15% share price gain to ₩12,550, the stock is trading at a trailing P/E ratio of 61.8x, up from the previous P/E ratio of 53.7x. This compares to an average P/E of 22x in the Electronic industry in South Korea. Total returns to shareholders over the past three years are 137%.
Valuation Update With 7 Day Price Move • Oct 29Market pulls back on stock over the past weekAfter last week's 18% share price decline to ₩10,450, the stock is trading at a trailing P/E ratio of 51.5x, down from the previous P/E ratio of 62.6x. This compares to an average P/E of 22x in the Electronic industry in South Korea. Total returns to shareholders over the past three years are 105%.
Valuation Update With 7 Day Price Move • Oct 21Market bids up stock over the past weekAfter last week's 36% share price gain to ₩10,750, the stock is trading at a trailing P/E ratio of 53x, up from the previous P/E ratio of 39x. This compares to an average P/E of 22x in the Electronic industry in South Korea. Total returns to shareholders over the past three years are 128%.
Is New 90 Day High Low • Oct 21New 90-day high: ₩10,750The company is up 86% from its price of ₩5,780 on 23 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 5.0% over the same period.
分析記事 • Jul 14Is DAIHAN Scientific Co., Ltd. (KOSDAQ:131220) A Good Fit For Your Dividend Portfolio?Today we'll take a closer look at DAIHAN Scientific Co., Ltd. (KOSDAQ:131220) from a dividend investor's perspective...